Ekersenin is widely used in the pharmaceutical industry as an intermediate in the synthesis of anti-inflammatory agents. It plays a key role in the development of topical treatments for skin conditions such as eczema and psoriasis due to its ability to modulate cellular responses in dermal tissues. Its selective reactivity makes it valuable in creating stable, long-acting formulations in transdermal drug delivery systems. Additionally, Ekersenin is employed in research settings to study enzyme inhibition pathways, particularly in kinases involved in inflammatory signaling. It is also utilized in the preparation of specialty polymers for biomedical devices, where biocompatibility and controlled degradation are essential.